Characterization of Patients with Guillain-Barré Syndrome in the General Hospital of Mexicali
Background: Guillain-Barré Syndrome is a progressive autoimmune polyradiculoneuropathy characterized by symmetrical flaccid paralysis accompanied by areflexia, hyporeflexia or hyperreflexia on rare occasions. Worldwide, it remains the first cause of flaccid paralysis. It is usually associated with infectious disease history; however, there are various clinical variants, each with a different outcome. Prognosis is usually good, although 20% of patients could suffer a severe clinical variant of Guillain-Barré Syndrome and 5% will die despite treatment.
Methods: This is a cross-sectional study, including the records of hospitalized patients with Guillain- Barré Syndrome at Mexicali’s General Hospital within a five-year period.
Results: In a five-year span there were 64 patients with Guillain-Barré Syndrome, most of the patients were men (70.3%), with age ranging 1 to 76 years. A total of 8 (12.5%) patients died, from which 7 (87.5%) required mechanical ventilation during hospitalization. Immunoglobulin therapy was provided to 56 (87.5%) patients, and 6 (10.7%) of them perished due to acute kidney injury.
Conclusion: Guillain-Barré Syndrome is a common disease among male population, with no dominating onset age, however, leaning for the young and elder. Most of the patients that were hospitalized at the General Hospital of Mexicali had a history of previous infection (gastrointestinal, respiratory, or other infectious diseases). The need for mechanical ventilation represents a higher severity index, nonetheless, this does not mean that assisted ventilation is directly associated with mortality. As for treatment, immunoglobulin is the most common choice for therapy, though some of the patients died from acute kidney injury.
Afifi AK. The Landry-Guillain-Barré Strohl Syndrome 1859 to 1992 A Historical Perspective. J Family Community Med. 1994 Jan-Dec;1(1):30–34.
Singhal V, Bhat KG. Guillain–Barre syndrome with hyperreflexia: A variant. J Pediatr Neurosci. 2011 Jul;6(2):144-5.
Medina BS, Vargas D, Rodríguez I, Orozco A, Hernández H. Descripción clínica y relación con la estancia hospitalaria de pacientes con síndrome de Guillain-Barré en un comunitario en México. Rev Mex Neurocienc. 2015 Marzo-Abril;16(2):3–15. Spanish.
Rebolledo-García D, González-Vargas PO, Salgado-Calderón I. Síndrome de Guillain-Barré: viejos y nuevos conceptos. Med Int Méx. 2018 enero;34(1):72-81. Spanish.
Yuki N, Hartung HP. Guillain–Barré Syndrome. N Engl J Med. 2012 Jun 14;366(24):2294-304.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2011 Mar;36(2):123–33.
Domínguez-Moreno R, Tolosa-Tort P, Patiño-Tamez A, Quintero-Bauman A, Collado-Frías DK, Miranda-Rodríguez MG, et al. Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions. Rev Neurol. 2014 Jan;58(1):4-10. Spanish.
Jackson BR, Zegarra JA, López-Gatell H, Sejvar J, Arzate F, Waterman S, et al. Binational outbreak of Guillain-Barré syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011. Epidemiol Infect. 2014 May;142(5):1089–99.
Romero MT, Franco T, Arzate F, García A, Terríquez A, Hernández N, et al.Guillain-Barré outbreak study in Ensenada, Baja California, Mexico.J Vaccines Vaccin 2018 March; 9:66
Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain J Neurol. 2014 Jan;137(Pt 1):33–43.
Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018 Oct 1;141(10):2866-2877
Hadden RD, Cornblath DR, Hugles RA, Zielasek J, Hartung HP, Tokya KV, et. al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol. 1998 Nov;44(5):780-8.
Asbury AK, Cornblath DR. Assessment of Current Diagnostic Criteria for Guillain-Barré Syndrome. Ann Neurol. 1990;27(suppl):S21-S24.
Luigetti Marco, Servidei Serenella, Modoni Anna, Rossini Paolo María, Sabatelli Mario, Monaci Mauro Lo. Admisión neurophysiological abnormalities un Guillain-Barré syndrome: A single-center experience. Clinical Neurology and Neurosurgery. 2015 Feb; 6-10.
Carrillo-Pérez DL, García-Ramos G, Ruano-Calderón LA, Sosa-Hernández JL, Méndez-Castillo JJ. Síndrome de Guillain-Barré en un hospital de referencia en México. Rev Mex Neuroci. 2012 Enero-Febrero;13(1):15-21. Spanish.
Palmezano JM, Rodríguez RM, Rangel DA, Galvis SJ, Camargo WA, Figueroa CL, et al.Perfil Clínico de Pacientes con Síndrome de Guillain Barre en un Hospital Universitario en Colombia. Archivos de medicina. 2017 Oct;13(4):1-6. Spanish.
Rudant J, Dupont A, Mikaeloff Y, Bolgert F, Coste J, Weill A. Surgery and risk of Guillain-Barré syndrome: A French nationwide epidemiologic study. Neurology. 2018 Sept;91(13):e1220–7.
Copyright (c) 2019 Fátima María Martínez-González, Jeremy Hernández-Ríos, Arely Gutiérrez, Andrés Beltrán, René González, Hiram Jaramillo-Ramírez
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to email@example.com
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to firstname.lastname@example.org